Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
GNC passes $2B in annual revenue; launches lift Watson earnings; NAI benefits from FDA supplement crackdown; PuraMed turns corner with LipiGesic M product rollout.
You may also be interested in...
Consumer Genome Sequencing Being Applied To Covid-19 New Variants In UK
The goal is to create a program which mass sequences SARS-CoV-2 samples in order to detect new variants, with £30m injected into the UK's hub for genomic sequencing in Cambridge.
Prices Plunge As Xarelto Generics Arrive In India
More than half a dozen generic rivaroxaban brands are now available in India, putting the heat on Bayer’s blockbuster anticoagulant Xarelto in the price-sensitive market. Many rival generics are priced over 50% lower than the innovator product.
France Rejects Advice To Delay Second Dose Of Pfizer Vaccine
The French government has decided not to extend the recommended interval between the two doses of the Pfizer/BioNTech coronavirus vaccine.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: